Report

Medicines in Development: Leukemia & Lymphoma 2013

Medicines in Development: Leukemia & Lymphoma

PhRMA April 24, 2013

Biopharmaceutical research companies are developing 241 medicines for blood cancers—leukemia, lymphoma and myeloma. This report lists medicines in human clinical trials or under review by the U.S. Food and Drug Administration (FDA).

Download